Adverum Biotechnologies, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Adverum Biotechnologies, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 20.9M shares, a 107% increase year-over-year.
  • Adverum Biotechnologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 101M shares, a 1.59% increase from 2022.
  • Adverum Biotechnologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 99.3M shares, a 1.24% increase from 2021.
  • Adverum Biotechnologies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 98M shares, a 15.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 20.9M +10.8M +107% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 20.9M +10.8M +107% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 16.5M +6.45M +64.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 101M +1.57M +1.59% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 10.1M -89.4M -89.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 10.1M -88.9M -89.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 10M -88.6M -89.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 99.3M +1.21M +1.24% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 99.5M +1.35M +1.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 99M +982K +1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 98.6M +846K +0.87% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 98M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 98.1M +9.26M +10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 98M +17.8M +22.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 97.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 88.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 80.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.